MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0092142
Innorex Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹22.73 Cr
▲ 90% YoY
Net profit · FY 2025
₹5.65 Cr
Net margin 24.8%
EBITDA · FY 2025
₹6.06 Cr
EBITDA margin 26.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.59 Cr
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Innorex Pharmaceuticals Private Limited
Data last updated:
Innorex Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC194675. Its GSTIN is 27AACCI1328L1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Raghunandan Rele and Shalaka Prashant Rele.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.73 Cr, a growth of 90% compared to the previous year. For the same year it recorded a net profit of ₹5.65 Cr (net margin 24.8%) and EBITDA of ₹6.06 Cr (EBITDA margin 26.6%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 10% over five years.
The company is associated with 1 brand: Innorex. As per MCA filings, the company has open charges of ₹5.59 Cr on record.
Innorex Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0092142). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innorexpharma.com.
Company details
CIN U24239MH2009PTC194675
Registration Number 194675
Incorporation Date 05 August 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0092142
Recognitions & Rankings of Innorex Pharmaceuticals
Contact details
Innorex Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is innorexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3D2 Gundecha Onclave Khairani Road Off. Saki Vihar Road Saki Naka Andheri, (East), Mumbai, Maharashtra, India – 400072
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Innorex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Innorex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Innorex Pharmaceuticals operates one associated brand: Innorex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical sourcing and supply services are offered by Innorex in India. | innorexpharma.com |
Business activity
The main business activity of Innorex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Innorex Pharmaceuticals Private Limited, buy the company report.
Financials of Innorex Pharmaceuticals Private Limited
FY 2025 filings availableInnorex Pharmaceuticals Private Limited reported revenue of ₹22.73 Cr (up 90% YoY) for FY 2025.
Revenue · FY 2025
₹22.73 Cr ▲ 90%
Net profit · FY 2025
₹5.65 Cr margin 24.8%
EBITDA · FY 2025
₹6.06 Cr margin 26.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 23%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 508%
3 years · compounded
▲ 66%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 90% growth in the latest year. EBITDA rose 508% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.65 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.6% | ||||
| Net Profit Margin | 24.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innorex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Innorex Pharmaceuticals Private Limited
Innorex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Raghunandan Rele | Director | 20 Aug 2018 | 8 Years 2 Months | Current |
| Shalaka Prashant Rele | Director | 05 Aug 2009 | 17 Years 2 Months | Current |
Auditor
Innorex Pharmaceuticals Private Limited is audited by S.K SOMANI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K SOMANI & ASSOCIATES | FY 2022 | 110365W |
Shareholding
The shareholding of Innorex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innorex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.59 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2020 | 100362483 | Others | ₹2.49 Cr | Open | |
| 21 Sep 2017 | 100153304 | Others | ₹3.1 Cr | Open |
To see the full charge records of Innorex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Innorex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Innorex Pharmaceuticals Private Limited was last rated by Crisil on 05 Sep 2017.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 05 Sep 2017 |
To see the full credit ratings and regulatory alerts of Innorex Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innorex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innorex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI1328L1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Innorex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Innorex Pharmaceuticals Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Prashant Raghunandan Rele ceased to be Director on 30 Aug 2018.
AGM
Innorex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innorex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others of Rs. 249.00 Lakh registered on 29 Aug 2020 with Charge ID 100362483 was modified on 25 Oct 2022.
Charges
A charge with Others amounted to Rs. 249.00 Lakh with Charge ID 100362483 was registered on 29 Aug 2020.
Charges
A charge with Others of Rs. 310.00 Lakh registered on 21 Sep 2017 with Charge ID 100153304 was modified on 26 Feb 2020.
Ceased
Prashant Raghunandan Rele ceased to be Director.
Ceased
Anjali Raghunandan Rele ceased to be Director.
Appointed
Prashant Raghunandan Rele was appointed as Director.
Charges
A charge with Others amounted to Rs. 310.00 Lakh with Charge ID 100153304 was registered on 21 Sep 2017.
Appointed
Shalaka Prashant Rele was appointed as Director.
Incorporation
05 Aug 2009
Innorex Pharmaceuticals Private Limited was registered on 05 Aug 2009 with Roc Mumbai I & aged 17 years 2 months as per MCA records.
Frequently asked questions
Innorex Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 2009 (17+ years old) and is registered under CIN U24239MH2009PTC194675.
Innorex Pharmaceuticals has 2 current directors:
- Prashant Raghunandan Rele - Director
- Shalaka Prashant Rele - Director
The latest financial statements of Innorex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innorex Pharmaceuticals is 27AACCI1328L1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Innorex Pharmaceuticals is U24239MH2009PTC194675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innorex Pharmaceuticals was incorporated on 05 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Prashant Raghunandan Rele ceased to be Director on 30 Aug 2018. Anjali Raghunandan Rele ceased to be Director on 20 Aug 2018. Prashant Raghunandan Rele was appointed as Director on 20 Aug 2018. Innorex Pharmaceuticals has 4 board changes on record in total.
Yes, Innorex Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0092142).
Innorex Pharmaceuticals can be reached through the website innorexpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Innorex Pharmaceuticals is at 3D2 Gundecha Onclave Khairani Road Off. Saki Vihar Road Saki Naka Andheri, East, Mumbai, Maharashtra, India – 400072.